Neurotoxic effect of oligomeric and fibrillar species of amyloid-beta peptide 1-42: Involvement of endoplasmic reticulum calcium release in oligomer-induced cell death

Neuroscience

Volumn 155, Issue 3, 2008, Pages 725-737

  Resende, R ^a   Ferreiro, E ^a   Pereira, C ^a   Resende de Oliveira, C ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Alzheimer's disease; amyloid beta peptide; calcium homeostasis; endoplasmic reticulum; fibrils; oligomers

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CALCIUM ION; CASPASE 3; DANTROLENE; INOSITOL 1,4,5 TRISPHOSPHATE; OLIGOMER; PHOSPHOLIPASE C; RYANODINE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN NERVE CELL; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DYSTROPHY; EMBRYO; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; RAT;

AMYLOID; AMYLOID BETA-PROTEIN; ANIMALS; CALCIUM; CASPASE 3; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; DENDRITES; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO, MAMMALIAN; ENDOPLASMIC RETICULUM; INOSITOL 1,4,5-TRISPHOSPHATE; MICROTUBULE-ASSOCIATED PROTEINS; NEURONS; NEUROTOXINS; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; TIME FACTORS;

EID: 49249118742     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.06.036     Document Type: Article

References (62)

1. 2+ uptake. Neurochem Res 15 (1990) 313-320
2. Behl C., Davis J.B., Lesley R., and Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77 (1994) 817-827
3. Berridge M.J., Lipp P., and Bootman M.D. Signal transduction. The calcium entry pas de deux. Science 287 (2000) 1604-1605
4. Cardoso S.M., Santos S., Swerdlow R.H., and Oliveira C.R. Functional mitochondria are required for amyloid beta-mediated neurotoxicity. FASEB J 15 (2001) 1439-1441
5. Casley C.S., Land J.M., Sharpe M.A., Clark J.B., Duchen M.R., and Canevari L. Beta-amyloid fragment 25-35 causes mitochondrial dysfunction in primary cortical neurons. Neurobiol Dis 10 (2002) 258-267
6. Cleary J.P., Walsh D.M., Hofmeister J.J., Shankar G.M., Kuskowski M.A., Selkoe D.J., and Ashe K.H. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci 8 (2005) 79-84
7. Cregan S.P., MacLaurin J.G., Craig C.G., Robertson G.S., Nicholson D.W., Park D.S., and Slack R.S. Bax-dependent caspase-3 activation is a key determinant in p-53-induced apoptosis in neurons. J Neurosci 19 (1999) 7860-7869
8. Dahlgren K.N., Manelli A.M., Stine W.B., Baker L.K., Krafft G.A., and LaDu M.J. Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability. J Biol Chem 277 (2002) 32046-32053
9. De Felice F.G., Velasco P.T., Lambert M.P., Viola K., Fernandez S.J., Ferreira S.T., and Klein W.L. Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem 282 (2007) 11590-11601
10. De Felice F.G., Wu D., Lambert M.P., Fernandez S.J., Velasco P.T., Lacor P.N., Bigio E.H., Jerecic J., Acton P.J., Shughrue P.J., Chen-Dodson E., Kinney G.G., and Klein W.L. Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Abeta oligomers. Neurobiol Aging (2007) doi:10.1016/j.neurobiolaging. 2007.02.029
11. Demuro A., Mina E., Kayed R., Milton S.C., Parker I., and Glabe C.G. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem 280 (2005) 17294-17300
12. Deshpande A., Mina E., Glabe C., and Busciglio J. Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons. J Neurosci 26 (2006) 6011-6018
13. Domingues A., Almeida S., da Cruz e Silva E.F., Oliveira C.R., and Rego A.C. Toxicity of beta-amyloid in HEK293 cells expressing NR1/NR2A or NR1/NR2B N-methyl-D-aspartate receptor subunits. Neurochem Int 50 (2007) 872-880
14. Dutta D. Mechanism of store-operated calcium entry. J Biosci 25 (2000) 397-404
15. Ferreiro E., Oliveira C.R., and Pereira C.M. The release of calcium from the endoplasmic reticulum induced by amyloid-beta and prion peptides activates the mitochondrial apoptotic pathway. Neurobiol Dis 30 (2008) 331-342
16. 2+ release through ryanodine and inositol 1,4,5-triphosphate receptors in the neurotoxic effects induced by the amyloid-beta peptide. J Neurosci Res 76 (2004) 872-880
17. Ferreiro E., Resende R., Costa R., Oliveira C.R., and Pereira C.M. An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity. Neurobiol Dis 23 (2006) 669-678
18. Finch E.A., Turner T.J., and Goldin S.M. Calcium as a coagonist of inositol 1,4,5-trisphosphate-induced calcium release. Science 252 (1991) 443-446
19. 2+]i. J Physiol 450 (1992) 217-246
20. Gong Y., Chang L., Viola K.L., Lacor P.N., Lambert M.P., Finch C.E., Krafft G.A., and Klein W.L. Alzheimer's disease-affected brain: presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci U S A 100 (2003) 10417-10422
21. Grace E.A., and Busciglio J. Aberrant activation of focal adhesion proteins mediates fibrillar amyloid beta-induced neuronal dystrophy. J Neurosci 23 (2003) 493-502
22. Grace E.A., Rabiner C.A., and Busciglio J. Characterization of neuronal dystrophy induced by fibrillar amyloid beta: implications for Alzheimer's disease. Neuroscience 114 (2002) 265-273
23. Guo Q., Sopher B.L., Furukawa K., Pham D.G., Robinson N., Martin G.M., and Mattson M.P. Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals. J Neurosci 17 (1997) 4212-4222
24. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002) 353-356
25. Hartley D.M., Walsh D.M., Ye C.P., Diehl T., Vasquez S., Vassilev P.M., Teplow D.B., and Selkoe D.J. Protofibrillar intermediates of amyloid β-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J Neurosci 19 (1999) 8876-8884
26. Hashioka S., Monji A., Ueda T., Kanba S., and Nakanishi H. Amyloid-β fibril formation is not necessarily required for microglial activation by the peptides. Neurochem Int 47 (2005) 369-376
27. Hedin H.L., Eriksson S., and Fowler C.J. Human platelet calcium mobilisation in response to beta-amyloid (25-35): buffer dependency and unchanged response in Alzheimer's disease. Neurochem Int 38 (2000) 145-151
28. Hertz E., Yua C.H., Hertz L., Juurlink B.H.J., and Schousboe A. Preparation of primary cultures of mouse cortical neurons. In: Shahar A., De Vellis J., Vernadakis A., and Haber B. (Eds). A dissection and tissue culture manual of the nervous system (1989), Alan R. Liss Inc, New York 183-186
29. Jayaraman T., and Marks A.R. T cells deficient in inositol 1,4,5-trisphosphate receptor are resistant to apoptosis. Mol Cell Biol 17 (1997) 3005-3012
30. Kaufman R.J. Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev 13 (1999) 1211-1233
31. Kelly B.L., and Ferreira A. Beta-Amyloid-induced dynamin 1 degradation is mediated by N-methyl-D-aspartate receptors in hippocampal neurons. J Biol Chem 281 (2006) 28079-28089
32. Klafki H.W., Wiltfang J., and Staufenbiel M. Electrophoretic separation of βA4 peptides (1-40) and (1-42). Anal Biochem 237 (1996) 24-29
33. Klein W.L., Krafft G.A., and Finch C.E. Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?. Trends Neurosci 24 (2001) 219-224
34. Kruman I., Bruce-Keller A.J., Bredesen D.W., Waeg G., and Mattson M.P. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J Neurosci 17 (1997) 5089-5100
35. Lacor P.N., Buniel M.C., Chang L., Fernandez S.J., Gong Y., Viola K.L., Lambert M.P., Velasco P.T., Bigio E.H., Finch C.E., Krafft G.A., and Klein W.L. Synaptic targeting by Alzheimer's related amyloid β oligomers. Neurobiol Dis 24 (2004) 10091-10200
36. Lambert M.P., Barlow A.K., Chromy B.A., Edwards C., Freed R., Liosatos M., Morgan T.E., Rozovsky I., Trommer B., Viola K.L., Wals P., Zhang C., Finch C.E., Krafft G.A., and Klein W.L. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A 98 (1998) 6448-6453
37. Lesné S., Koh M.T., Kotilinek L., Kayed R., Glabe C.G., Yang A., Gallagher M., and Ashe K.H. A specific amyloid-β protein assembly in the brain impairs memory. Nature 440 (2006) 352-357
38. Lindholm D., Wootz H., and Korhonen L. ER stress and neurodegenerative diseases. Cell Death Differ 13 (2006) 385-392
39. Lorenzo A., and Yankner B. β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc Natl Acad Sci U S A 91 (1994) 12243-12247
40. Masliah E., Honer W.G., Mallory M., Voigt M., Kushner P., Hansen L., and Terry R. Topographical distribution of synaptic-associated proteins in the neuritic plaques of Alzheimer's disease hippocampus. Acta Neuropathol (Berl) 87 (1994) 135-142
41. Mattson M.P., Cheng B., Davis D., Bryant K., Lieberburg I., and Rydel R.E. β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 12 (2002) 376-389
42. McLean C.A., Cherny R.A., Fraser F.W., Fuller S.J., Smith M.J., Beyreuther K., Bush A.I., and Masters C.L. Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol 46 (1999) 860-866
43. Mikoshiba K. Inositol 1,4,5-trisphosphate IP(3) receptors and their role in neuronal cell function. J Neurochem 97 (2006) 1627-1633
44. Mosmann T. Rapid colorimetric assay for cellular growth and survival. J Immunol Methods 65 (1983) 55-63
45. Mucke L., Masliah E., Yu G.Q., Mallory M., Rockenstein E.M., Tatsuno G., Hu K., Kholodenko D., Johnson-Wood K., and McConlogue L. High-level neuronal expression of Aβ 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci 20 (2000) 4050-4058
46. Naslund J., Haroutunian V., Mohs R., Davis K.L., Davies P., Greengard P., and Buxbaum J.D. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA 283 (2000) 1571-1577
47. 2+ by caffeine and ryanodine induces apoptosis of Chinese hamster ovary cells transfected with ryanodine receptor. J Biol Chem 275 (2000) 19978-19984
48. Paschen W. Dependence of vital cell function on endoplasmic reticulum calcium levels: implications for the mechanisms underlying neuronal cell injury in different pathological states. Cell Calcium 29 (2001) 1-11
49. Pereira C., Santos M.S., and Oliveira C. Mitochondrial function impairment induced by amyloid beta-peptide on PC12 cells. Neuroreport 9 (1998) 1749-1755
50. Pereira C., Santos M.S., and Oliveira C. Involvement of oxidative stress on the impairment of energy metabolism induced by Abeta peptides on PC12 cells: protection by antioxidants. Neurobiol Dis 6 (1999) 209-219
51. Pike C.J., Burdick D., Walencewicz A.J., Glabe C.G., and Cotman C.W. Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci 13 (1993) 1676-1687
52. Resende R., Ferreiro E., Pereira C., and Oliveira C.R. ER stress is involved in Abeta-induced GSK-3beta activation and tau phosphorylation. J Neurosci Re 86 (2008) 2091-2099
53. 2+ homeostasis. Brain Res 1143 (2007) 11-21
54. Richardson J.C., Kendal C.E., Anderson R., et al. Ultrastructural and behavioural changes precede amyloid deposition in a transgenic model of Alzheimer's disease. Neuroscience 122 (2003) 213-228
55. Shankar G.M., Bloodgood B.L., Townsend M., Walsh D.M., Selkoe D.J., and Sabatini B.L. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 27 (2007) 2866-2875
56. Shimmyo Y., Kihara T., Akaike A., Niidome T., and Sugimoto H. Multifunction of myricetin on Abeta neuroprotection via a conformational change of Abeta and reduction of Abeta via the interference of secretases. J Neurosci Res 86 (2008) 368-377
57. Singh I.N., Sorrentino G., and Kanfer J.N. Amyloid beta protein (25-35) stimulation of phospholipase C in LA-N-2 cells. J Neurochem 69 (1997) 252-258
58. Townsend M., Shankar G.M., Mehta T., Walsh D.M., and Selkoe D.J. Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers. J Physiol 572 (2006) 477-492
59. Tsai J., Grutzendler J., Duff K., and Gan W.B. Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nat Neurosci 11 (2004) 1181-1183
60. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., and Selkoe D.J. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416 (2002) 535-539
61. 2+. J Physiol 458 (1992) 319-338
62. Zou K., Gong J.S., Yanagisawa K., and Michikawa M. A novel function of monomeric amyloid beta-protein serving as an antioxidant molecule against metal-induced oxidative damage. J Neurosci 22 (2002) 4833-4841